In The News

Long-term Fosamax® Use and Fracture Link Raises Concern

A growing number of reports have orthopedic doctors concerned over the possible link between the long-term use of the medication Fosamax® and a particular type of thighbone (femur) fracture.  Doctors prescribe Fosamax, generically referred to as bisphosphonate alendronate, to prevent and treat diseases that cause bone weakening in both men and women.  Doctors prescribe it most frequently for osteoporosis; a leading cause of bone weakening that occurs with the natural aging process and contributes to bone fractures.  Fosamax slows bone degeneration, while increasing bone strength and reducing fracture risk. 
Although Fosamax lowers the risk of fractures associated with osteoporosis and other bone disorders, there is mounting concern over the long-term use of this drug. According to the New England Journal of Medicine, Journal of Orthopaedic Trauma, and Injury, uncommon stress fractures in the thigh-bone have occurred in patients treated with Fosamax from 18 months to 10 years. The fractures occurred after minimal or no trauma and had poor healing.

More research is underway, and until then, people taking Fosamax should:

• Discuss any concerns with their doctors
• Report thigh pain, tenderness, or swelling to their doctors
• Discontinue Fosamax if they develop a stress fracture as determined by their doctor, unless the benefits outweigh the harm.

For more information or to schedule an appointment, call South Palm Orthopedics at (561) 496-6622 or use our online appointment request form.